H.L. Atkins

617 total citations
19 papers, 446 citations indexed

About

H.L. Atkins is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, H.L. Atkins has authored 19 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Radiation. Recurrent topics in H.L. Atkins's work include Radiopharmaceutical Chemistry and Applications (9 papers), Medical Imaging Techniques and Applications (7 papers) and Advanced Radiotherapy Techniques (3 papers). H.L. Atkins is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Medical Imaging Techniques and Applications (7 papers) and Advanced Radiotherapy Techniques (3 papers). H.L. Atkins collaborates with scholars based in United States. H.L. Atkins's co-authors include Alfred P. Wolf, A.N. Ansari, David R. Christman, Ralph G. Fairchild, Joanna S. Fowler, V Casella, P. Som, Brian M. Gallagher, M. Reivich and Robert MacGregor and has published in prestigious journals such as Radiology, Journal of Medicinal Chemistry and American Journal of Roentgenology.

In The Last Decade

H.L. Atkins

19 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.L. Atkins United States 10 283 116 67 65 59 19 446
Tatsunosuke Hiraki Japan 13 274 1.0× 101 0.9× 57 0.9× 37 0.6× 33 0.6× 51 491
R.S. Benua United States 9 344 1.2× 123 1.1× 93 1.4× 73 1.1× 115 1.9× 19 645
A.N. Ansari United States 11 536 1.9× 142 1.2× 30 0.4× 60 0.9× 122 2.1× 20 800
F. Helus Germany 8 230 0.8× 77 0.7× 82 1.2× 69 1.1× 33 0.6× 32 343
Bruce W. Wieland United States 12 244 0.9× 96 0.8× 31 0.5× 86 1.3× 26 0.4× 24 414
P.R. Bradley-Moore United States 5 297 1.0× 62 0.5× 39 0.6× 30 0.5× 47 0.8× 6 415
Itsuko Ando Japan 14 350 1.2× 157 1.4× 100 1.5× 24 0.4× 36 0.6× 59 587
R.S. Tilbury United States 15 551 1.9× 178 1.5× 66 1.0× 143 2.2× 45 0.8× 39 846
Pál Mikecz Hungary 14 296 1.0× 86 0.7× 53 0.8× 112 1.7× 42 0.7× 37 519
Johannes F. Klopper South Africa 11 199 0.7× 148 1.3× 28 0.4× 24 0.4× 101 1.7× 35 489

Countries citing papers authored by H.L. Atkins

Since Specialization
Citations

This map shows the geographic impact of H.L. Atkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.L. Atkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.L. Atkins more than expected).

Fields of papers citing papers by H.L. Atkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.L. Atkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.L. Atkins. The network helps show where H.L. Atkins may publish in the future.

Co-authorship network of co-authors of H.L. Atkins

This figure shows the co-authorship network connecting the top 25 collaborators of H.L. Atkins. A scholar is included among the top collaborators of H.L. Atkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.L. Atkins. H.L. Atkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Srivastava, S.C., H.L. Atkins, Gerbail T. Krishnamurthy, et al.. (1998). Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.. PubMed. 4(1). 61–8. 62 indexed citations
2.
Atkins, H.L., L.F. Mausner, S.C. Srivastava, et al.. (1993). Biodistribution of Sn-117m(4+)DTPA for palliative therapy of painful osseous metastases.. Radiology. 186(1). 279–283. 42 indexed citations
3.
Shreeve, Walton W., et al.. (1987). Phantom gallbladder. A variant of the rim sign.. PubMed. 12(6). 457–60. 7 indexed citations
4.
Reivich, M., Joel Greenberg, A.P. Wolf, et al.. (1984). The evaluation of the lumped constant for deoxyglucose and fluorodeoxyglucose in man. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations
5.
Oster, Z.H., et al.. (1983). Desferal (DFO) induced 67Ga washout from normal tissue, tumor and abscess in experimental animals. International Journal of Nuclear Medicine and Biology. 10(1). 48–49. 1 indexed citations
6.
Gallagher, Brian M., A.N. Ansari, H.L. Atkins, et al.. (1977). Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(10). 990–6. 151 indexed citations
7.
Fowler, Joanna S., R. R. MacGregor, A. P. Wolf, A.N. Ansari, & H.L. Atkins. (1976). Radiopharmaceuticals. 16. Halogenated dopamine analogs. Synthesis and radiolabeling of 6-iododopamine and tissue distribution studies in animals. Journal of Medicinal Chemistry. 19(3). 356–360. 19 indexed citations
8.
Packer, Samuel, et al.. (1975). Quinoline Analog Labeled With Iodine 123 in Melanoma Detection. Archives of Ophthalmology. 93(7). 504–508. 19 indexed citations
9.
Ansari, A.N., et al.. (1975). Note on the distribution of iodine-123-labeled indocyanine green in the eye. XVIII.. PubMed. 14(10). 780–2. 1 indexed citations
10.
Lambrecht, Richard M., et al.. (1974). A novel 123I-labeling reagent. XIII. Synthesis and loading-dose effects of 123I-iodophenylalanine and 123I-5- and6-iodotryptophan.. PubMed. 15(10). 863–7. 12 indexed citations
11.
Atkins, H.L., Ralph G. Fairchild, & Ruth M. Drew. (1973). BIOLOGICAL PROPERTIES OF 252CF. American Journal of Roentgenology. 117(3). 704–710. 8 indexed citations
12.
Atkins, H.L., et al.. (1972). Organic radiopharmaceuticals labeled with isotopes of short half-life. V. 18 F-labeled 5- and 6-fluorotryptophan.. PubMed. 13(10). 713–9. 39 indexed citations
13.
Robertson, James S., Ralph G. Fairchild, & H.L. Atkins. (1972). Dosimetry of Californium 252. Radiology. 104(2). 393–398. 3 indexed citations
14.
Atkins, H.L., et al.. (1970). Comparison of Irradiation by Californium 252 and Radium on the Skin of Swine. Radiology. 96(1). 161–165. 14 indexed citations
15.
Fairchild, Ralph G., Ruth M. Drew, & H.L. Atkins. (1970). The Oxygen Enhancement Ratio for Protracted Irradiation with252Cf. Radiology. 96(3). 661–665. 5 indexed citations
16.
Fairchild, Ralph G., Ruth M. Drew, & H.L. Atkins. (1969). The Relative Biological Effect of252Cf Radiation on HeLa Cells in Culture. Radiology. 93(5). 1187–1189. 12 indexed citations
17.
Atkins, H.L.. (1966). PRACTICAL MODIFICATIONS OF THE RECTILINEAR SCANNER. American Journal of Roentgenology. 97(4). 888–895. 6 indexed citations
18.
Atkins, H.L.. (1966). Conduct of a controlled clinical trial.. BMJ. 2(5510). 377–379. 42 indexed citations
19.
Atkins, H.L., et al.. (1961). Interstitial Irradiation of Brain Tumors with Iridium 192. Radiology. 77(5). 842–843. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026